Telomir Pharmaceuticals director Craig Eagle resigns from board, effective Nov 14, 2025

Telomir Pharmaceuticals, Inc.

Craig Eagle resigned from the Board of Directors on November 14, 2025, effective immediately.
Resignation was not due to any disagreement with the Company, management, or other board members.
The Board thanked Mr. Eagle for his service; no successor has been announced.
Resignation letter attached as Exhibit 17.1 to the 8-K.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.